FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092855696> ?p ?o ?g. }

• W2092855696 abstract "Many hormones are secreted in a pulsatile fashion that is more efficient than continuous secretion when tested in vivo. A trial of multiple daily insulin doses with or without the addition of weekly pulsatile insulin infusion therapy was designed to determine if deterioration of renal and retinal function could be blunted. Sixty-five study subjects were evaluated prospectively in 7 centers. Thirty-six patients were randomly allocated to the infusion group and 29 to the standard therapy group. Mean serum creatinine was 1.6 mg/dL in both groups. Subjects were excluded if clearance was less than 30 mL/min. There were no significant differences between the groups with respect to age, duration of diabetes, sex distribution, glycohemoglobin, blood pressure, angiotensin-converting enzyme inhibitor use, proteinuria, or baseline diabetic retinopathy (DR) severity level (all eyes exhibited DR; 8 were deemed technically not amenable to evaluation). Progression of DR was noted in 31.6% of 57 patients (32.3% treated, 30.8% control; P = 1.0) with both eyes evaluable. For patients with 12 or more months of follow-up, 27.9% of 43 patients demonstrated progression of DR (32.0% treated, 22.2% control; P = .57). There were no significant differences between study groups with respect to progression or marked progression, nor was there any influence of duration of follow-up. Progression of DR was noted in 18.8% of 122 eyes that could be adequately evaluated (17.9% of 67 treated, 20% of 55 controls; P = .39). Serum creatinine increased to 1.7 mg/dL in the treatment group and to 1.9 mg/dL in the control group (P = .03). Statistically significant preservation of renal function by pulsatile insulin infusion was not matched by a statistically significant prevention of DR progression compared with standard diabetes care. Inadequate statistical power or duration of the study, or lack of further benefit of pulsatile insulin infusion on the retina in the presence of angiotensin-converting enzyme inhibition may be responsible." @default.
• W2092855696 created "2016-06-24" @default.
• W2092855696 creator A5011697010 @default.
• W2092855696 creator A5014110930 @default.
• W2092855696 creator A5028259750 @default.
• W2092855696 creator A5033996338 @default.
• W2092855696 creator A5049285095 @default.
• W2092855696 creator A5067110312 @default.
• W2092855696 creator A5075668584 @default.
• W2092855696 creator A5087059050 @default.
• W2092855696 creator A5090080754 @default.
• W2092855696 date "2010-10-01" @default.
• W2092855696 modified "2023-10-16" @default.
• W2092855696 title "Pulsatile intermittent intravenous insulin therapy for attenuation of retinopathy and nephropathy in type 1 diabetes mellitus" @default.
• W2092855696 cites W1981346654 @default.
• W2092855696 cites W1982558842 @default.
• W2092855696 cites W1998986488 @default.
• W2092855696 cites W2018196775 @default.
• W2092855696 cites W2030696232 @default.
• W2092855696 cites W2032224136 @default.
• W2092855696 cites W2036686750 @default.
• W2092855696 cites W2047088101 @default.
• W2092855696 cites W2047691266 @default.
• W2092855696 cites W2053107240 @default.
• W2092855696 cites W2057595956 @default.
• W2092855696 cites W2058709097 @default.
• W2092855696 cites W2062408616 @default.
• W2092855696 cites W2076886097 @default.
• W2092855696 cites W2078641298 @default.
• W2092855696 cites W2098016188 @default.
• W2092855696 cites W2105347271 @default.
• W2092855696 cites W2108266187 @default.
• W2092855696 cites W2109020094 @default.
• W2092855696 cites W2114258502 @default.
• W2092855696 cites W2133695167 @default.
• W2092855696 cites W2138884529 @default.
• W2092855696 cites W2140647387 @default.
• W2092855696 cites W2162994762 @default.
• W2092855696 cites W2163916552 @default.
• W2092855696 cites W2188850292 @default.
• W2092855696 cites W2414275950 @default.
• W2092855696 cites W2615684303 @default.
• W2092855696 cites W2319268509 @default.
• W2092855696 doi "https://doi.org/10.1016/j.metabol.2010.01.004" @default.
• W2092855696 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20189608" @default.
• W2092855696 hasPublicationYear "2010" @default.
• W2092855696 type Work @default.
• W2092855696 sameAs 2092855696 @default.
• W2092855696 citedByCount "9" @default.
• W2092855696 countsByYear W20928556962012 @default.
• W2092855696 countsByYear W20928556962013 @default.
• W2092855696 countsByYear W20928556962015 @default.
• W2092855696 countsByYear W20928556962016 @default.
• W2092855696 countsByYear W20928556962018 @default.
• W2092855696 countsByYear W20928556962019 @default.
• W2092855696 countsByYear W20928556962020 @default.
• W2092855696 crossrefType "journal-article" @default.
• W2092855696 hasAuthorship W2092855696A5011697010 @default.
• W2092855696 hasAuthorship W2092855696A5014110930 @default.
• W2092855696 hasAuthorship W2092855696A5028259750 @default.
• W2092855696 hasAuthorship W2092855696A5033996338 @default.
• W2092855696 hasAuthorship W2092855696A5049285095 @default.
• W2092855696 hasAuthorship W2092855696A5067110312 @default.
• W2092855696 hasAuthorship W2092855696A5075668584 @default.
• W2092855696 hasAuthorship W2092855696A5087059050 @default.
• W2092855696 hasAuthorship W2092855696A5090080754 @default.
• W2092855696 hasConcept C126322002 @default.
• W2092855696 hasConcept C134018914 @default.
• W2092855696 hasConcept C159641895 @default.
• W2092855696 hasConcept C2778313320 @default.
• W2092855696 hasConcept C2779306644 @default.
• W2092855696 hasConcept C2779561371 @default.
• W2092855696 hasConcept C2779829184 @default.
• W2092855696 hasConcept C2780091579 @default.
• W2092855696 hasConcept C2780306776 @default.
• W2092855696 hasConcept C2780401358 @default.
• W2092855696 hasConcept C2781184683 @default.
• W2092855696 hasConcept C555293320 @default.
• W2092855696 hasConcept C71924100 @default.
• W2092855696 hasConcept C79191276 @default.
• W2092855696 hasConcept C84393581 @default.
• W2092855696 hasConceptScore W2092855696C126322002 @default.
• W2092855696 hasConceptScore W2092855696C134018914 @default.
• W2092855696 hasConceptScore W2092855696C159641895 @default.
• W2092855696 hasConceptScore W2092855696C2778313320 @default.
• W2092855696 hasConceptScore W2092855696C2779306644 @default.
• W2092855696 hasConceptScore W2092855696C2779561371 @default.
• W2092855696 hasConceptScore W2092855696C2779829184 @default.
• W2092855696 hasConceptScore W2092855696C2780091579 @default.
• W2092855696 hasConceptScore W2092855696C2780306776 @default.
• W2092855696 hasConceptScore W2092855696C2780401358 @default.
• W2092855696 hasConceptScore W2092855696C2781184683 @default.
• W2092855696 hasConceptScore W2092855696C555293320 @default.
• W2092855696 hasConceptScore W2092855696C71924100 @default.
• W2092855696 hasConceptScore W2092855696C79191276 @default.
• W2092855696 hasConceptScore W2092855696C84393581 @default.
• W2092855696 hasLocation W20928556961 @default.
• W2092855696 hasLocation W20928556962 @default.
• W2092855696 hasOpenAccess W2092855696 @default.
• W2092855696 hasPrimaryLocation W20928556961 @default.

• next